These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16502765)

  • 1. Absence of a food effect with a 145 mg nanoparticle fenofibrate tablet formulation.
    Sauron R; Wilkins M; Jessent V; Dubois A; Maillot C; Weil A
    Int J Clin Pharmacol Ther; 2006 Feb; 44(2):64-70. PubMed ID: 16502765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Lidose hard capsule formulation of fenofibrate is suprabioavailable compared to the nanoparticle tablet formulation under high-fat fed conditions.
    Verbeeck RK; De Niet S; Lebrun S; Tremege M; Rennie TW; Coffiner M; Streel B; Cahay B
    J Pharm Pharm Sci; 2015; 18(1):61-7. PubMed ID: 25877442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics.
    Jones MR; Baker BA; Mathew P
    Clin Pharmacokinet; 2004; 43(13):943-50. PubMed ID: 15509187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.
    Guivarc'h PH; Vachon MG; Fordyce D
    Clin Ther; 2004 Sep; 26(9):1456-69. PubMed ID: 15531008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.
    Yun HY; Joo Lee E; Youn Chung S; Choi SO; Kee Kim H; Kwon JT; Kang W; Kwon KI
    Clin Pharmacokinet; 2006; 45(4):425-32. PubMed ID: 16584288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and bioequivalence of two fenofibrate choline formulations in healthy subjects under fed and fasted condition
.
    Park JM; Chae SI; Noh YS; Lee SJ; Shim WS; Yoon JM; Hwang SJ; Lee KT; Chung EK
    Int J Clin Pharmacol Ther; 2019 Apr; 57(4):217-228. PubMed ID: 30802201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, randomized, three-way crossover trial of the effects of coadministration of rosuvastatin and fenofibrate on the pharmacokinetic properties of rosuvastatin and fenofibric acid in healthy male volunteers.
    Martin PD; Dane AL; Schneck DW; Warwick MJ
    Clin Ther; 2003 Feb; 25(2):459-71. PubMed ID: 12749507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.
    Metzmann K; Schnell D; Jungnik A; Ring A; Theodor R; Hohl K; Meinicke T; Friedrich C
    Int J Clin Pharmacol Ther; 2014 Jul; 52(7):549-63. PubMed ID: 24755124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacokinetics of two fenofibrate tablet formulations in healthy human subjects.
    Chachad SS; Gole M; Malhotra G; Naidu R
    Clin Ther; 2014 Jun; 36(6):967-73. PubMed ID: 24844853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the effect of 3 different diets on the bioavailability of 2 sustained release theophylline matrix tablets.
    Gai MN; Isla A; Andonaegui MT; Thielemann AM; Seitz C
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):565-71. PubMed ID: 9455715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers.
    Sonet B; Vanderbist F; Streel B; Houin G
    Arzneimittelforschung; 2002; 52(3):200-4. PubMed ID: 11963648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers.
    Vlase L; Popa A; Muntean D; Leucuta SE
    Arzneimittelforschung; 2010; 60(9):560-3. PubMed ID: 21117499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer.
    Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG
    Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
    Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.
    Gandelman K; Lamson M; Salageanu J; Bramson C; Matschke K; Malhotra B
    Clin Pharmacol Drug Dev; 2015 Sep; 4(5):370-6. PubMed ID: 27137146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism-based pharmacokinetic model of fenofibrate for explaining increased drug absorption after food consumption.
    Back HM; Song B; Pradhan S; Chae JW; Han N; Kang W; Chang MJ; Zheng J; Kwon KI; Karlsson MO; Yun HY
    BMC Pharmacol Toxicol; 2018 Jan; 19(1):4. PubMed ID: 29370865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.